Log In
Print
BCIQ
Print
Print this Print this
 

Anthrax immune globulin IV (AIGIV), Anthrivig

Also known as: Anthrax Immune Globulin (AIG)

  Manage Alerts
Collapse Summary General Information
Company Emergent BioSolutions Inc.
DescriptionAnthrax immune globulin developed using plasma collected from healthy donors vaccinated with the company's BioThrax
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationAnthrax
Indication DetailsTreat inhalation anthrax
Regulatory Designation

U.S. - Fast Track (Treat inhalation anthrax)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today